Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

from Cancer via ola Kala on Inoreader http://ift.tt/2xhIvAL
via IFTTT